About Us
Silverback is a biopharmaceutical company seeking victory for patients by developing novel, tissue-targeted therapies designed to result in life-changing outcomes.
Our approach modulates fundamental pathways in a tissue-localized manner, sparing healthy cells from harmful side effects.
Our team has an unwavering commitment to patients through our tenacity, boldness, and a keen focus on science, addressing devastating diseases in the areas of chronic viral infections, cancer, and other serious diseases.
